Shenzhen Chipscreen Biosciences Hits Day High with 9.31% Surge

Shenzhen Chipscreen Biosciences Co., Ltd. has experienced a significant uptick in its stock performance, gaining 9.31% on June 29, 2026. The stock reached an intraday high of CNY 26.22, showcasing notable activity in the pharmaceuticals and biotechnology sector. In terms of performance metrics, Shenzhen Chipscreen has outperformed the China Shanghai Composite index, which recorded a modest gain of 1.16% on the same day. Over the past week, the company’s stock has risen by 4.05%, contrasting with a decline of 2.14% in the broader market. However, the stock has faced challenges over the longer term, with a year-to-date performance of -10.4% compared to the index's gain of 2.65%. Despite these fluctuations, the company reported impressive quarterly results, including a pre-tax profit growth of 2,552.93% and a net profit increase of 538.37%. With a market capitalization of CNY 9,986 million, Shenzhen Chipscreen continues to navigate a complex financial landscape, marked by both growth opportunities and underlying challenges.